The treatment for sinusitis in a young child with a penicillin allergy is:

Rationale: A. For children with a non-type 1 penicillin allergy, a third-generation cephalosporin like cefdinir is the recommended alternative for treating bacterial sinusitis. It provides the necessary coverage against Haemophilus influenzae and Moraxella catarrhalis while being generally well-tolerated by pediatric patients. This choice balances the need for effective bacterial clearance with the requirement to avoid a potential allergic reaction to the penicillin class. B. Amoxicillin is a member of the aminopenicillin class and is strictly contraindicated in a patient with a known penicillin allergy. Administering this drug could lead to hypersensitivity reactions ranging from a mild rash to life-threatening anaphylaxis. While it is the first-line treatment for children without allergies, its use in this specific scenario is a significant safety violation that could harm the patient. C. Sulfamethoxazole/Trimethoprim is not recommended for sinusitis in children due to the high prevalence of resistance among Streptococcus pneumoniae and Haemophilus influenzae. Using an agent with poor clinical efficacy increases the risk of complications such as orbital cellulitis or chronic sinus issues. Current pediatric guidelines prioritize cephalosporins over sulfonamides when penicillin cannot be used to ensure better clinical outcomes and faster symptom resolution. D. Tetracyclines like doxycycline are generally avoided in young children, typically those under the age of 8, due to the risk of permanent tooth discoloration and interference with bone growth. While some recent guidelines allow for short courses in specific situations, they are not the preferred second-line choice for pediatric sinusitis. A third-generation cephalosporin remains the safer and more standard pharmacological option for this patient population.